Treatment of lymphoma with adoptively transferred T cells

Por Till, Brian G., Press, Oliver W.
Publicado em 2009

Depletion of Tregs for adoptive T-cell therapy using CD44 and CD137 as selection markers

Por Till, Brian G, Press, Oliver W
Publicado em 2012

Prospects for chimeric antigen receptor (CAR) γδ T cells: a potential game changer for adoptive T cell cancer immunotherapy

Por Mirzaei, Hamid Reza, Mirzaei, Hamed, Lee, Sang Yun, Hadjati, Jamshid, Till, Brian G.
Publicado no Cancer Lett (2016)

Antigen sensitivity of CD22-specific chimeric T cell receptors is modulated by target epitope distance from the cell membrane

Por James, Scott E., Greenberg, Philip D., Jensen, Michael C., Lin, Yukang, Wang, Jinjuan, Till, Brian G., Raubitschek, Andrew A., Forman, Stephen J., Press, Oliver W.
Publicado em 2008

Bendamustine, etoposide, and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in non-Hodgkin lymphoma

Por Greenbaum, Adam M., Green, Damian J., Holmberg, Leona A., Gooley, Ted, Till, Brian G., Budde, Lihua E., Rasmussen, Heather, Press, Oliver W., Gopal, Ajay K.
Publicado no Blood Res (2018)

Effect of Remission Status and Induction Chemotherapy Regimen on Outcome of Autologous Stem Cell Transplantation for Mantle Cell Lymphoma

Por Till, Brian G., Gooley, Theodore A., Crawford, Nathan, Gopal, Ajay K., Maloney, David G., Petersdorf, Stephen H., Pagel, John M., Holmberg, Leona, Bensinger, William, Press, Oliver W.
Publicado em 2008

Mathematical modeling of chimeric TCR triggering predicts the magnitude of target lysis and its impairment by TCR down-modulation

Por James, Scott E., Greenberg, Philip D., Jensen, Michael C., Lin, Yukang, Wang, Jinjuan, Budde, Lihua E., Till, Brian G., Raubitschek, Andrew A., Forman, Stephen J., Press, Oliver W.
Publicado em 2010

Combining a CD20 Chimeric Antigen Receptor and an Inducible Caspase 9 Suicide Switch to Improve the Efficacy and Safety of T Cell Adoptive Immunotherapy for Lymphoma

Por Budde, Lihua E., Berger, Carolina, Lin, Yukang, Wang, Jinjuan, Lin, Xubin, Frayo, Shani E., Brouns, Shaunda A., Spencer, David M., Till, Brian G., Jensen, Michael C., Riddell, Stanley R., Press, Oliver W.
Publicado em 2013

Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myeloma

Por Green, Damian J., Bensinger, William I., Holmberg, Leona A., Gooley, Ted, Till, Brian G., Budde, Lihua E., Pagel, John M., Frayo, Shani L., Roden, Jennifer E., Hedin, Lacey, Press, Oliver W., Gopal, Ajay K.
Publicado no Bone Marrow Transplant (2016)

Preclinical optimization of a CD20-specific chimeric antigen receptor vector and culture conditions

Por Lee, Sang Yun, Olsen, Philip, Lee, Dong Hoon, Kenoyer, Aimee L., Budde, Lihua E., O’Steen, Shyril, Green, Damian J., Heimfeld, Shelly, Jensen, Michael C., Riddell, Stanley R., Press, Oliver W., Till, Brian G.
Publicado no J Immunother (2018)

Recommendations for Clinical Trial Development in Mantle Cell Lymphoma

Por Spurgeon, Stephen E., Till, Brian G., Martin, Peter, Goy, Andre H., Dreyling, Martin P., Gopal, Ajay K., LeBlanc, Michael, Leonard, John P., Friedberg, Jonathan W., Baizer, Lawrence, Little, Richard F., Kahl, Brad S., Smith, Mitchell R.
Publicado no J Natl Cancer Inst (2016)

Preserved Activity of CD20-Specific Chimeric Antigen Receptor-Expressing T cells in the Presence of Rituximab

Por Rufener, Gregory A., Press, Oliver W., Olsen, Philip, Lee, Sang Yun, Jensen, Michael C., Gopal, Ajay K., Pender, Barbara, Budde, Lihua E., Rossow, Jeffrey K., Green, Damian J., Maloney, David G., Riddell, Stanley R., Till, Brian G.
Publicado no Cancer Immunol Res (2016)

Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601

Por Till, Brian G., Li, Hongli, Bernstein, Steven H., Fisher, Richard I., Burack, W. Richard, Rimsza, Lisa M., Floyd, Justin D., DaSilva, Marco A., Moore, Dennis F., Pozdnyakova, Olga, Smith, Sonali M., LeBlanc, Michael, Friedberg, Jonathan W.
Publicado no Br J Haematol (2015)

Mantle Cell Lymphoma International Prognostic Index but Not Pretransplantation Induction Regimen Predicts Survival for Patients With Mantle-Cell Lymphoma Receiving High-Dose Therap...

Por Budde, Lihua E., Guthrie, Katherine A., Till, Brian G., Press, Oliver W., Chauncey, Thomas R., Pagel, John M., Petersdorf, Steven H., Bensinger, William I., Holmberg, Leona A., Shustov, Andrei R., Green, Damian J., Maloney, David G., Gopal, Ajay K.
Publicado em 2011

CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results

Por Till, Brian G., Jensen, Michael C., Wang, Jinjuan, Qian, Xiaojun, Gopal, Ajay K., Maloney, David G., Lindgren, Catherine G., Lin, Yukang, Pagel, John M., Budde, Lihua E., Raubitschek, Andrew, Forman, Stephen J., Greenberg, Philip D., Riddell, Stanley R., Press, Oliver W.
Publicado em 2012

Venetoclax Synergizes with Radiotherapy for Treatment of B-cell Lymphomas

Por O’Steen, Shyril, Green, Damian J., Gopal, Ajay K., Orozco, Johnnie J., Kenoyer, Aimee L., Lin, Yukang, Wilbur, D. Scott, Hamlin, Donald K., Fisher, Darrell R., Hylarides, Mark D., Gooley, Theodore A., Waltman, Amelia, Till, Brian G., Press, Oliver W.
Publicado no Cancer Res (2017)

Safety of allogeneic hematopoietic cell transplant in adults after CD19-targeted CAR T-cell therapy

Por Shadman, Mazyar, Gauthier, Jordan, Hay, Kevin A., Voutsinas, Jenna M., Milano, Filippo, Li, Ang, Hirayama, Alexandre V., Sorror, Mohamed L., Cherian, Sindhu, Chen, Xueyan, Cassaday, Ryan D., Till, Brian G., Gopal, Ajay K., Sandmaier, Brenda M., Maloney, David G., Turtle, Cameron J.
Publicado no Blood Adv (2019)

Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells

Por Till, Brian G., Jensen, Michael C., Wang, Jinjuan, Chen, Eric Y., Wood, Brent L., Greisman, Harvey A., Qian, Xiaojun, James, Scott E., Raubitschek, Andrew, Forman, Stephen J., Gopal, Ajay K., Pagel, John M., Lindgren, Catherine G., Greenberg, Philip D., Riddell, Stanley R., Press, Oliver W.
Publicado em 2008

Autologous transplant for relapsed follicular lymphoma: impact of pre-transplant rituximab sensitivity

Por Phipps, Colin, Gopal, Ajay K., Storer, Barry E., Cassaday, Ryan D., Press, Oliver W., Till, Brian G., Pagel, John M., Palanca-Wessels, Maria C., Philip, Mary, Bensinger, William I., Holmberg, Leona A., Shustov, Andrei R., Green, Damian J., Chauncey, Thomas, Maloney, David G., Libby, Edward N.
Publicado no Leuk Lymphoma (2014)

Brentuximab vedotin administered to platinum-refractory, transplant-naïve Hodgkin lymphoma patients can increase the proportion achieving FDG PET negative status

Por Onishi, Maika, Graf, Solomon A., Holmberg, Leona, Behnia, Sanaz, Shustov, Andrei R., Schiavo, Karen, Philip, Mary, Libby, Edward N., Cassaday, Ryan D., Pagel, John M., Roden, Jennifer E., Maloney, David G., Green, Damian J., Till, Brian G., Press, Oliver W., Smith, Stephen D., Gopal, Ajay K.
Publicado no Hematol Oncol (2014)